Osteoporosis--a risk factor for cardiovascular diseases: a follow-up study. 2015

Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović

BACKGROUND Cardiovascular (CV) diseases and bone fractures due to osteoporosis are the leading causes of death in the elderly. OBJECTIVE The aim of this study was to demonstrate a correlation between the overall risk for CV events, and low bone density in postmenopausal women, and its impact on the incidence of serious CV events. METHODS Our prospective study involved 300 postmenopausal women. All the examinees were divided into three groups based on their measured bone density: Group I--84 examinees with osteoporosis; Group II--115 examinees with osteopenia; and Group III--101 examinees with normal bone density. In all examinees the overall ten-year risk for a fatal CV event was calculated using the SCORE system tables. RESULTS After a 36-month follow-up, CV events occurred in 19 (6.3%) examinees. Significant differences in the incidence of CV events were demonstrated between the patients with osteoporosis, osteopenia, and normal bone density (χ2 = 28.7; p < 0.001), as well as between those with a high and low CV risk (χ2 = 22.6; p < 0.001). Multivariate logistic regression analysis showed that smoking (OR: 2.23; 95% CI: 1.02 to 6.19; p = 0.035), and increase of overall CV score (OR: 1.36; 95% CI: 1.17 to 1.58; p < 0.001) are associated with increased CV event risk, while the increase of T score value is associated with decreased risk of CV event (OR: 0.42; 95% CI: 0.25 to 0.73; p = 0.002). CONCLUSIONS Measurement of bone density with a standard assessment of the total CV risk could be useful for selecting women who need intensive prevention and treatment of atherosclerosis.

UI MeSH Term Description Entries
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
October 2012, Nature reviews. Rheumatology,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
February 2010, Clinical nursing research,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
January 2019, Clinical calcium,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
December 2003, Journal of human hypertension,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
May 1989, Hypertension (Dallas, Tex. : 1979),
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
January 1999, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
January 2013, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
April 2014, British journal of hospital medicine (London, England : 2005),
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
October 2016, The Journal of clinical psychiatry,
Ivan Tasić, and Marina Rašić Popović, and Sonja Stojanović, and Bojana Stamenković, and Svetlana Kostić, and Dejan Popović, and Gordana Lazarević, and Dragan Bogdanović, and Vladisav Stefanović
April 1949, Journal of the American Medical Association,
Copied contents to your clipboard!